How a pill approved 25 years ago transformed cancer treatment

AI Summary

Gleevec, approved by the FDA 25 years ago, significantly changed the landscape of cancer treatment by offering a targeted therapy for leukemia. This advance has paved the way for further innovations in oncology.

When the Food and Drug Administration approved Gleevec to treat a form of leukemia in 2001, it ushered in a new era in cancer care.